Apheresis Market

The global apheresis devices market is projected to reach USD 4.41 billion by 2031 from USD 3.02 billion in 2026, growing at a CAGR of 7.9% during the forecast period.

The apheresis market is growing rapidly due to the increasing global burden of hematological, autoimmune, neurological, and renal disorders, along with the expanding adoption of cell and gene therapies. The increasing adoption of apheresis therapy and donor procedures, coupled with technological developments in apheresis equipment, has led to improvements in the efficiency and safety of these procedures. High demand for plasma-derived therapies and favorable reimbursement policies are further fueling market growth.

To know about the assumptions considered for the study download the pdf brochure

• In March 2026, Terumo Blood and Cell Technologies partnered with Taiwan Bio Therapeutics for the development of Treg cell therapy using the Quantum Flex platform
• In December 2024, Fresenius Kabi collaborated with Ori Biotech to advance modular and scalable manufacturing solutions for cell and gene therapies through integrated automation and manufacturing technologies.

The prominent players in the apheresis market include Terumo Corporation (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Fresenius Medical Care AG (Germany), Asahi Kasei Medical Co., Ltd. (Japan), Becton, Dickinson and Company (US), Macopharma SA (France), Miltenyi Biotec (Germany), Therakos LLC (US), Toray Industries Inc. (Japan), Kaneka Corporation (Japan), and B. Braun SE (Germany).

Terumo Corporation (Japan)

Terumo Corporation (Japan) is a global medtech company dedicated to R&D, manufacturing, commercialization, and sale of apheresis-related products.  The company’s portfolio includes 3 business segments – cardiac and vascular company, medical care solutions company, and blood and technology company. The company provides a range of apheresis systems, blood component collection systems, therapeutic apheresis technology, blood processing systems, and disposables through its Blood and Cell Technologies division. Terumo develops & manufactures products across Africa, Asia Pacific, Europe, Latin America, North America, South America, and the Middle East in more than 160+ countries. The major subsidiaries include Terumo BCT, Inc. (US), Terumo Europe NV (Belgium), Caridian BCT Biotechnologies (US), and Caridian BCT Europe NV/SA (Belgium).

Fresenius SE & Co. KGaA (Germany)

Fresenius SE & Co. KGaA is a leading healthcare company, primarily focused on manufacturing products and devices worldwide, for a wide range of acute and chronic diseases. The company provides a broad portfolio of essential healthcare products across 4 major business segments: Pharma, Nutrition, MedTech, and Biopharma. Within the apheresis market, Fresenius primarily operates through its MedTech segment, particularly through Fresenius Kabi, which offers products for platelet collection, plasma collection, leukapheresis, stem cell collection, therapeutic plasma exchange, LDL apheresis, immunoadsorption, and blood component processing. The company has a global presence across Asia Pacific, Europe, and North America. Its leading subsidiaries include Fresenius Kabi USA, LLC, Fresenius Kabi Canada, and Fresenius Kabi Australia Pty Limited.

Haemonetics Corporation (US)

Haemonetics Corporation is a global blood management solutions company that manufactures and distributes products that support blood collection, blood processing, transfusion management, and cell processing workflows. The company sells products in more than 95 countries across various regions through its subsidiaries, including Haemonetics Software Solutions LLC, Global Med Technologies, LLC, and Haemonetics Mexico Manufacturing S. de R.L. de C.V., as well as regional sales and distribution entities in Europe and Asia.

Market Ranking

The apheresis market is consolidated, dominated by major players, Terumo Corporation (Japan), Fresenius SE & Co. KGaA (Germany), and Haemonetics Corporation (US), accounting for the largest share of the market. The leading players have strong global networks and established distribution across regions such as North America and Europe. These companies leverage partnerships, advanced R&D, and brand strength to maintain their lead. Meanwhile, smaller players compete by offering low-cost products and innovative technologies, resulting in a market landscape that combines dominant global companies with agile, competitive regional providers.

Related Reports:

Apheresis Market by Product (Device, Disposable), Procedure [Donor, Therapeutic (Neurological, Blood)], Application (Plasmapheresis, Plateletpheresis), Technology (Centrifugation, Membrane Separation), End User (Clinic) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]